ArticleCell death & disease2021

Anti-tumor activity of a novel proteasome inhibitor D395 against multiple myeloma and its lower cardiotoxicity compared with carfilzomib.

Xuxing Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.